Clinical trial reportArthritis & rheumatology (Hoboken, N.J.)Published
Efficacy and Safety of Guselkumab in Participants With Active Psoriatic Arthritis After Inadequate Response to One Prior Tumor Necrosis Factor Inhibitor: Week-24 Results of a Phase 3, Randomized, Placebo-Controlled Study
Regional connection
Verified Author affiliations on the Europe PMC record name Drexel University College of Medicine, Johnson & Johnson, Perelman School of Medicine, University of Pennsylvania, with Drexel University linked by the institution reference. Affiliation source
Publication record
- Type
- Clinical trial report
- Venue
- Arthritis & rheumatology (Hoboken, N.J.)
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Arthritis, Psoriatic; Tumor Necrosis Factor-alpha; Antirheumatic Agents; Treatment Outcome; Severity of Illness Index; Cross-Over Studies; Double-Blind Method; Adult; Middle Aged; Female; Male
- PubMed ID
- 41670439
- PubMed Central ID
- PMC13430097
- Open access
- Yes, open
- Added to directory
- Source checked